 6. Participant has not been on any previous therapy with androgen receptor antagonists or mTOR inhibitors. Note: patients who have taken an androgen receptor antagonist for a brief period no more than 2 months at the start of LHRH agonist therapy to prevent flare will be considered eligible. 